These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30112050)
1. Compound Wu C; Kan H; Hu M; Liu X; Boye A; Jiang Y; Wu J; Wang J; Yang X; Yang Y Exp Ther Med; 2018 Aug; 16(2):1052-1060. PubMed ID: 30112050 [TBL] [Abstract][Full Text] [Related]
2. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism. Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513 [TBL] [Abstract][Full Text] [Related]
3. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling. Hu X; Rui W; Wu C; He S; Jiang J; Zhang X; Yang Y J Gastroenterol Hepatol; 2014 Jun; 29(6):1284-91. PubMed ID: 24329763 [TBL] [Abstract][Full Text] [Related]
4. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation. Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748 [TBL] [Abstract][Full Text] [Related]
5. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell. Liu X; Yang Y; Zhang X; Xu S; He S; Huang W; Roberts MS J Gastroenterol Hepatol; 2010 Feb; 25(2):420-6. PubMed ID: 19793165 [TBL] [Abstract][Full Text] [Related]
6. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription. Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078 [TBL] [Abstract][Full Text] [Related]
7. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts. Yang Y; Yang S; Chen M; Zhang X; Zou Y; Zhang X J Ethnopharmacol; 2008 Jul; 118(2):264-70. PubMed ID: 18502066 [TBL] [Abstract][Full Text] [Related]
8. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway. He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214 [TBL] [Abstract][Full Text] [Related]
9. Compound Astragalus and Salvia miltiorrhiza extract suppresses rabbits' hypertrophic scar by modulating the TGF-β/Smad signal. Wu C; Jiang J; Boye A; Jiang Y; Yang Y Dermatology; 2014; 229(4):363-8. PubMed ID: 25171116 [TBL] [Abstract][Full Text] [Related]
10. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma. Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684 [TBL] [Abstract][Full Text] [Related]
11. Ovarian transforming growth factor-beta (TGF-beta) receptors: in-vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-beta on receptor expression in human preantral follicles. Roy SK; Kole AR Mol Hum Reprod; 1998 Mar; 4(3):207-14. PubMed ID: 9570266 [TBL] [Abstract][Full Text] [Related]
12. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III. Deng X; Bellis S; Yan Z; Friedman E Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts. Zhao Y Mol Cell Endocrinol; 1999 Apr; 150(1-2):91-7. PubMed ID: 10411303 [TBL] [Abstract][Full Text] [Related]
14. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption. Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794 [TBL] [Abstract][Full Text] [Related]
15. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. Tao YY; Wang QL; Shen L; Fu WW; Liu CH Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154 [TBL] [Abstract][Full Text] [Related]
17. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors. Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548 [TBL] [Abstract][Full Text] [Related]
18. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II. McLean S; Di Guglielmo GM Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198 [TBL] [Abstract][Full Text] [Related]
19. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas. Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754 [TBL] [Abstract][Full Text] [Related]
20. [Chinese herbal medicine Fuzheng Huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/Smads signaling pathway]. Wang QL; Tao YY; Shen L; Cui HY; Liu CH Zhong Xi Yi Jie He Xue Bao; 2012 May; 10(5):561-8. PubMed ID: 22587979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]